Patent Yard Sign in
Canadian application, no grantCanada

Human embryonic germ cell line and methods of use

CA 2285274 A1 · Owner: Shamblott, Michael Joseph · Inventors: Shamblott, Michael Joseph; Gearhart, John D.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Primordial germ cells isolated from human embryonic tissue such as from the , gonadal ridges of human embryo are disclosed. The primordial germ cells are cultured resulting in cells that resemble embryonic stem cells or embryonic germ cells in morphology and pluripotency. The cells are maintained several months in culture and can be genetically manipulated using transgenic technology to insert heterologous genetic material.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 31, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 31, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 31, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 31, 1998
GrantedNo grant recorded
Term endedMarch 31, 2018
Patent numberCA 2285274 A1
Classification (IPC)C12N5/07 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedMarch 31, 1998Term endedMarch 31, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.